Cholesterol Exacerbates the Pathophysiology of Non-Alcoholic Steatohepatitis by Upregulating Hypoxia-Inducible Factor 1 and Modulating Microcirculatory Dysfunction

• Published in: Nutrients Vol. 15; no. 24; p. 5034
• Main Authors: Pereira, Evelyn Nunes Goulart da Silva, Araujo, Beatriz Peres de, Rodrigues, Karine Lino, Silvares, Raquel Rangel, Guimarães, Fernanda Verdini, Martins, Carolina Souza Machado, Flores, Edgar Eduardo Ilaquita, Silva, Patrícia Machado Rodrigues E, Daliry, Anissa
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-12-2023
• Subjects: Cholesterol; Cytokines; Enzymes; Glucose; Hypoxia; Inflammation; Insulin resistance; Laboratory animals; lipotoxicity; Liver diseases; MacDonald, Alan David; Metabolism; microcirculation; nonalcoholic fatty liver disease; Brazil; United States > US; South San Francisco California; nonalcoholic fatty liver disease; inflammation; microcirculation; lipotoxicity
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15245034

Cholesterol is a pivotal lipotoxic molecule that contributes to the progression of Non-Alcoholic Steatohepatitis NASH). Additionally, microcirculatory changes are critical components of Non-Alcoholic Fatty Liver Disease (NAFLD) pathogenesis. This study aimed to investigate the role of cholesterol as an insult that modulates microcirculatory damage in NAFLD and the underlying mechanisms. The experimental model was established in male C57BL/6 mice fed a high-fat high-carbohydrate (HFHC) diet for 39 weeks. Between weeks 31-39, 2% cholesterol was added to the HFHC diet in a subgroup of mice. Leukocyte recruitment and hepatic stellate cells (HSC) activation in microcirculation were assessed using intravital microscopy. The hepatic microvascular blood flow (HMBF) was measured using laser speckle flowmetry. High cholesterol levels exacerbated hepatomegaly, hepatic steatosis, inflammation, fibrosis, and leukocyte recruitment compared to the HFHC group. In addition, cholesterol decreased the HMBF-cholesterol-induced activation of HSC and increased HIF1A expression in the liver. Furthermore, cholesterol promoted a pro-inflammatory cytokine profile with a Th1-type immune response (IFN-γ/IL-4). These findings suggest cholesterol exacerbates NAFLD progression through microcirculatory dysfunction and HIF1A upregulation through hypoxia and inflammation. This study highlights the importance of cholesterol-induced lipotoxicity, which causes microcirculatory dysfunction associated with NAFLD pathology, thus reinforcing the potential of lipotoxicity and microcirculation as therapeutic targets for NAFLD.